Skip to content

StatLab CB500-100

by Yancheng Huida Medical Instruments Co., Ltd.

StatLab CB500-100 is a general-purpose cytology brush (FDA Class I; FDA product code GEE, Brush, Biopsy, General & Plastic Surgery) made by Yancheng Huida Medical Instruments Co., Ltd., listed in FDA GUDID since 1 May 2024 (UDI-DI 06971317521776), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number06971317521776 UDI-DI Date1 May 2024ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Cervical brush, sterile, scored
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
StatLab
Generic name
General-purpose cytology brush
Model / reference
CB500-100
Primary DI / UDI-DI
06971317521776
FDA product code
GEE
GMDN term
General-purpose cytology brush
Device class
Class I
Regulation number
878.4800
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code GEE (Brush, Biopsy, General & Plastic Surgery).

Other devices from Yancheng Huida Medical Instruments Co., Ltd.

See all devices from Yancheng Huida Medical Instruments Co., Ltd. →

Properties

  • Supplied sterile
  • Single use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (9, all answered No)